Lv4
590 积分 2025-10-16 加入
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
21天前
已完结
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
21天前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
22天前
已完结
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
1个月前
已完结
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
3个月前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
3个月前
已完结
Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study
3个月前
已关闭
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
6个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
6个月前
已完结
皖公网安备34019202002308
